240 related articles for article (PubMed ID: 22724610)
1. Reappraisal of acetazolamide for the prevention of acute mountain sickness: a systematic review and meta-analysis.
Kayser B; Dumont L; Lysakowski C; Combescure C; Haller G; Tramèr MR
High Alt Med Biol; 2012 Jun; 13(2):82-92. PubMed ID: 22724610
[TBL] [Abstract][Full Text] [Related]
2. Interventions for preventing high altitude illness: Part 1. Commonly-used classes of drugs.
Nieto Estrada VH; Molano Franco D; Medina RD; Gonzalez Garay AG; Martí-Carvajal AJ; Arevalo-Rodriguez I
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD009761. PubMed ID: 28653390
[TBL] [Abstract][Full Text] [Related]
3. Day of Ascent Dosing of Acetazolamide for Prevention of Acute Mountain Sickness.
Lipman GS; Jurkiewicz C; Winstead-Derlega C; Navlyt A; Burns P; Walker A; Phillips C; Reilly A; Burnier A; Romero J; Warner K; Hackett P
High Alt Med Biol; 2019 Sep; 20(3):271-278. PubMed ID: 31259608
[No Abstract] [Full Text] [Related]
4. Efficacy of Acetazolamide for the Prophylaxis of Acute Mountain Sickness: A Systematic Review, Meta-Analysis and Trial Sequential Analysis of Randomized Clinical Trials.
Gao D; Wang Y; Zhang R; Zhang Y
Am J Med Sci; 2021 May; 361(5):635-645. PubMed ID: 33587912
[TBL] [Abstract][Full Text] [Related]
5. Acetazolamide for the prevention of acute mountain sickness--a systematic review and meta-analysis.
Ritchie ND; Baggott AV; Andrew Todd WT
J Travel Med; 2012; 19(5):298-307. PubMed ID: 22943270
[TBL] [Abstract][Full Text] [Related]
6. Acetazolamide and prevention of acute mountain sickness.
Prescrire Int; 2014 Nov; 23(154):273. PubMed ID: 25954800
[TBL] [Abstract][Full Text] [Related]
7. Low-dose acetylsalicylic acid analog and acetazolamide for prevention of acute mountain sickness.
Kayser B; Hulsebosch R; Bosch F
High Alt Med Biol; 2008; 9(1):15-23. PubMed ID: 18331216
[TBL] [Abstract][Full Text] [Related]
8. Effects of acetazolamide on pulmonary artery pressure and prevention of high-altitude pulmonary edema after rapid active ascent to 4,559 m.
Berger MM; Sareban M; Schiefer LM; Swenson KE; Treff F; Schäfer L; Schmidt P; Schimke MM; Paar M; Niebauer J; Cogo A; Kriemler S; Schwery S; Pickerodt PA; Mayer B; Bärtsch P; Swenson ER
J Appl Physiol (1985); 2022 Jun; 132(6):1361-1369. PubMed ID: 35511718
[TBL] [Abstract][Full Text] [Related]
9. Altitude, Acute Mountain Sickness, and Acetazolamide: Recommendations for Rapid Ascent.
Toussaint CM; Kenefick RW; Petrassi FA; Muza SR; Charkoudian N
High Alt Med Biol; 2021 Mar; 22(1):5-13. PubMed ID: 32975448
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review.
Dumont L; Mardirosoff C; Tramèr MR
BMJ; 2000 Jul; 321(7256):267-72. PubMed ID: 10915127
[TBL] [Abstract][Full Text] [Related]
11. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial.
Chow T; Browne V; Heileson HL; Wallace D; Anholm J; Green SM
Arch Intern Med; 2005 Feb; 165(3):296-301. PubMed ID: 15710792
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness.
van Patot MC; Leadbetter G; Keyes LE; Maakestad KM; Olson S; Hackett PH
High Alt Med Biol; 2008; 9(4):289-93. PubMed ID: 19115912
[TBL] [Abstract][Full Text] [Related]
13. A Randomized Controlled Trial of the Lowest Effective Dose of Acetazolamide for Acute Mountain Sickness Prevention.
Lipman GS; Jurkiewicz C; Burnier A; Marvel J; Phillips C; Lowry C; Hawkins J; Navlyt A; Swenson ER
Am J Med; 2020 Dec; 133(12):e706-e715. PubMed ID: 32479750
[TBL] [Abstract][Full Text] [Related]
14. Acetazolamide to Prevent Adverse Altitude Effects in COPD and Healthy Adults.
Furian M; Mademilov M; Buergin A; Scheiwiller PM; Mayer L; Schneider S; Emilov B; Lichtblau M; Bitos K; Muralt L; Groth A; Reiser AE; Sevik A; Sheraliev U; Marazhapov NH; Aydaralieva S; Muratbekova A; Tabyshova A; Abdraeva A; Buenzli S; Sooronbaev TM; Ulrich S; Bloch KE
NEJM Evid; 2022 Jan; 1(1):EVIDoa2100006. PubMed ID: 38296630
[TBL] [Abstract][Full Text] [Related]
15. Identifying the lowest effective dose of acetazolamide for the prophylaxis of acute mountain sickness: systematic review and meta-analysis.
Low EV; Avery AJ; Gupta V; Schedlbauer A; Grocott MP
BMJ; 2012 Oct; 345():e6779. PubMed ID: 23081689
[TBL] [Abstract][Full Text] [Related]
16. Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial.
Basnyat B; Gertsch JH; Holck PS; Johnson EW; Luks AM; Donham BP; Fleischman RJ; Gowder DW; Hawksworth JS; Jensen BT; Kleiman RJ; Loveridge AH; Lundeen EB; Newman SL; Noboa JA; Miegs DP; O'Beirne KA; Philpot KB; Schultz MN; Valente MC; Wiebers MR; Swenson ER
High Alt Med Biol; 2006; 7(1):17-27. PubMed ID: 16544963
[TBL] [Abstract][Full Text] [Related]
17. Acetazolamide plus low-dose dexamethasone is better than acetazolamide alone to ameliorate symptoms of acute mountain sickness.
Bernhard WN; Schalick LM; Delaney PA; Bernhard TM; Barnas GM
Aviat Space Environ Med; 1998 Sep; 69(9):883-6. PubMed ID: 9737760
[TBL] [Abstract][Full Text] [Related]
18. Effects of acetazolamide on cognitive performance during high-altitude exposure.
Wang J; Ke T; Zhang X; Chen Y; Liu M; Chen J; Luo W
Neurotoxicol Teratol; 2013; 35():28-33. PubMed ID: 23280141
[TBL] [Abstract][Full Text] [Related]
19. Findings of Cognitive Impairment at High Altitude: Relationships to Acetazolamide Use and Acute Mountain Sickness.
Phillips L; Basnyat B; Chang Y; Swenson ER; Harris NS
High Alt Med Biol; 2017 Jun; 18(2):121-127. PubMed ID: 28509579
[TBL] [Abstract][Full Text] [Related]
20. Determinants of summiting success and acute mountain sickness on Mt Kilimanjaro (5895 m).
Davies AJ; Kalson NS; Stokes S; Earl MD; Whitehead AG; Frost H; Tyrell-Marsh I; Naylor J
Wilderness Environ Med; 2009; 20(4):311-7. PubMed ID: 20030437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
